About M K Proteins Limited
Data last updated:
M K Proteins Limited is a public limited company based in Ambala, Haryana, India. It operates in the edible oils and cooking fats segment of the food and beverages sector. It was incorporated on 15 June 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN L15500HR2012PLC046239. Its GSTIN is 06AAHCM9854C1ZB (Haryana). It is a listed company as per MCA records. Its shares are listed on BSE: 543919 and NSE: MKPL.
The company has an authorised share capital of ₹40 Cr and a paid-up capital of ₹37.54 Cr. It was formerly known as M K Proteins Private Limited. It is led by directors including Parmod Kumar (Managing Director) and Vinod Kumar (Whole-Time Director).
Its last annual general meeting (AGM) was held on 19 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Naraingarh Road Vill. Garnala, Ambala, Haryana, India – 134003.
As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹382.88 Cr, a growth of 43% compared to the previous year. For the same year it recorded a net profit of ₹6.83 Cr (net margin 1.8%) and EBITDA of ₹11.42 Cr (EBITDA margin 3%). The net worth stands at ₹76.3 Cr (up 9.8% YoY). Total assets are valued at ₹113.82 Cr (up 4.9% YoY).
The company has about 52 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: M.K. Proteins. As per MCA filings, the company has open charges of ₹42.53 Cr and satisfied charges of ₹16.25 Cr on record. Court records list 12 cases involving the company, including 6 filed by the company and 6 filed against it; 3 cases are pending. The company has 36 deals on record (35 market trades, 1 ipo); the latest was in March 2024.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mkproteins.in.
Company details
CIN history
M K Proteins has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L15500HR2012PLC046239, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L15500HR2012PLC046239 | Current |
| U15500HR2012PLC046239 | Previous |
| U15500HR2012PTC046239 | Previous |
Contact details
M K Proteins Limited's registered office is in Ambala, Haryana. Its website is mkproteins.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNaraingarh Road Vill. Garnala, Ambala, Haryana, India – 134003
- IndustryFood and Beverages, Edible Oils & Cooking Fats
To see the full contact details of M K Proteins Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
M K Proteins operates one associated brand: M.K. Proteins. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| mkproteins.in |
Business activity
The main business activities of M K Proteins are manufacturing and trade. In detail, this covers manufacture of food products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 10 | Manufacture of food products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of M K Proteins Limited, buy the company report.
Financials of M K Proteins Limited
FY 2025-26 filings availableM K Proteins Limited reported revenue of ₹382.88 Cr (up 43% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 383 | 268 | 246 | 315 | 256 | 311 | 194 |
| Revenue growth | +43.0% | +9.0% | -22.0% | +23.1% | -17.8% | +60.3% | - |
| EBITDA | 11.42 | 12.50 | 16.64 | 17.15 | 15.72 | 16.00 | 4.81 |
| EBITDA margin | +3.0% | +4.7% | +6.8% | +5.5% | +6.1% | +5.1% | +2.5% |
| Profit before tax | 9.39 | 11.47 | 15.46 | 14.98 | 14.06 | 14.32 | 2.43 |
| Net profit | 6.83 | 8.09 | 11.17 | 10.91 | 10.16 | 10.36 | 1.77 |
| Net profit margin | +1.8% | +3.0% | +4.6% | +3.5% | +4.0% | +3.3% | +0.9% |
| EPS (₹) | 0.18 | 0.22 | 0.30 | 8.74 | 24.42 | 24.91 | 4.36 |
| Balance sheet | |||||||
| Total assets | 114 | 109 | 81.39 | 95.59 | 76.47 | 54.52 | 49.56 |
| Net worth | 76.30 | 69.47 | 61.08 | 49.86 | 39.60 | 29.34 | 18.95 |
| Total debt | 37.14 | 38.72 | 20.08 | 45.53 | 36.78 | 25.13 | 30.57 |
| Cash & bank | 0.44 | 0.03 | 0.09 | 0.06 | 0.01 | 0.00 | 0.11 |
| Net working capital | 101 | 96.45 | 70.98 | 90.96 | 72.64 | 51.36 | 45.83 |
| Cash flow | |||||||
| Cash from operations | 5.43 | (16.13) | 32.42 | (5.87) | (10.12) | 5.54 | (4.47) |
| Cash from investing | (1.60) | (1.48) | (5.88) | 0.01 | (1.53) | (0.21) | 0.18 |
| Cash from financing | (3.43) | 17.55 | (26.51) | 5.92 | 11.66 | (5.44) | 4.40 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 115 | 146 | 89.56 | 32.43 | 115 | 137 | 39.48 | 33.69 |
| Revenue growth (YoY) | +0.2% | +6.4% | +126.9% | -3.7% | +100.5% | - | - | - |
| Other income | 0.00 | 0.12 | 0.02 | 0.12 | 0.00 | 0.02 | 0.25 | 0.21 |
| Total expenses | 113 | 143 | 87.19 | 31.39 | 109 | 133 | 37.68 | 31.45 |
| EBITDA | 2.51 | 2.50 | 2.37 | 1.04 | 5.51 | 4.65 | 1.80 | 2.24 |
| EBITDA margin | +2.2% | +1.7% | +2.6% | +3.2% | +4.8% | +3.4% | +4.6% | +6.6% |
| Depreciation | 0.15 | 0.11 | 0.12 | 0.11 | 0.10 | 0.09 | 0.11 | 0.07 |
| Interest | 0.52 | 0.79 | 0.30 | 0.06 | 0.70 | 0.67 | 0.07 | 0.03 |
| Profit before tax | 1.84 | 1.72 | 1.97 | 0.99 | 4.71 | 3.91 | 1.87 | 2.35 |
| Tax | 0.47 | 0.58 | 0.53 | 0.25 | 1.19 | 1.12 | 0.48 | 0.59 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 115 | 146 | 89.56 | 32.43 | 115 | 137 | 39.48 | 33.69 |
| Revenue growth (YoY) | +0.2% | +6.4% | +126.9% | -3.7% | +100.5% | - | - | - |
| Other income | 0.00 | 0.12 | 0.02 | 0.12 | 0.00 | 0.02 | 0.25 | 0.21 |
| Total expenses | 113 | 143 | 87.19 | 31.39 | 109 | 133 | 37.68 | 31.45 |
| EBITDA | 2.51 | 2.50 | 2.37 | 1.04 | 5.51 | 4.65 | 1.80 | 2.24 |
| EBITDA margin | +2.2% | +1.7% | +2.6% | +3.2% | +4.8% | +3.4% | +4.6% | +6.6% |
| Depreciation | 0.15 | 0.11 | 0.12 | 0.11 | 0.10 | 0.09 | 0.11 | 0.07 |
| Interest | 0.52 | 0.79 | 0.30 | 0.06 | 0.70 | 0.67 | 0.07 | 0.03 |
| Profit before tax | 1.84 | 1.72 | 1.97 | 0.99 | 4.71 | 3.91 | 1.87 | 2.35 |
| Tax | 0.47 | 0.58 | 0.53 | 0.25 | 1.19 | 1.12 | 0.48 | 0.59 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 383 | 268 | 246 | 315 | 256 | 311 | 194 |
| Revenue growth | +43.0% | +9.0% | -22.0% | +23.1% | -17.8% | +60.3% | - |
| Other income | 0.26 | 0.48 | 0.45 | 0.55 | 0.14 | 0.05 | 0.31 |
| Total expenses | 371 | 255 | 229 | 298 | 240 | 295 | 189 |
| Employee cost | 0.00 | 1.79 | 1.83 | 1.49 | 1.70 | 1.43 | 1.44 |
| EBITDA | 11.42 | 12.50 | 16.64 | 17.15 | 15.72 | 16.00 | 4.81 |
| EBITDA margin | +3.0% | +4.7% | +6.8% | +5.5% | +6.1% | +5.1% | +2.5% |
| Depreciation | 0.44 | 0.35 | 0.53 | 0.82 | 0.91 | 0.91 | 1.17 |
| Interest | 1.85 | 1.16 | 1.10 | 1.90 | 0.89 | 0.82 | 1.52 |
| Profit before tax | 9.39 | 11.47 | 15.46 | 14.98 | 14.06 | 14.32 | 2.43 |
| Tax | 2.56 | 3.06 | 4.26 | 4.06 | 3.86 | 3.93 | 0.63 |
| Net profit | 6.83 | 8.09 | 11.17 | 10.91 | 10.16 | 10.36 | 1.77 |
| Net profit margin | +1.8% | +3.0% | +4.6% | +3.5% | +4.0% | +3.3% | +0.9% |
| EPS (₹) | 0.18 | 0.22 | 0.30 | 8.74 | 24.42 | 24.91 | 4.36 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 37.54 | 37.54 | 37.54 | 12.51 | 4.17 | 4.17 | 4.17 |
| Reserves & surplus | 38.76 | 31.93 | 23.54 | 37.35 | 35.43 | 25.17 | 14.78 |
| Shareholders' funds (net worth) | 76.30 | 69.47 | 61.08 | 49.86 | 39.60 | 29.34 | 18.95 |
| Secured loans | 36.19 | 37.75 | 19.09 | 44.52 | 36.78 | 25.13 | 26.61 |
| Unsecured loans | 0.95 | 0.97 | 0.99 | 1.01 | 0.00 | 0.00 | 3.96 |
| Total debt | 37.14 | 38.72 | 20.08 | 45.53 | 36.78 | 25.13 | 30.57 |
| Total liabilities | 114 | 109 | 81.39 | 95.59 | 76.47 | 54.52 | 49.56 |
| Assets | |||||||
| Gross block | 14.13 | 13.39 | 12.48 | 12.41 | 11.47 | 9.90 | 3.10 |
| Net block | 4.73 | 3.68 | 2.77 | 3.29 | 3.11 | 2.46 | 3.10 |
| Capital work in progress | 7.10 | 6.66 | 5.90 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventories | 110 | 111 | 79.27 | 71.20 | 49.77 | 37.70 | 38.99 |
| Sundry debtors | 2.11 | 1.40 | 3.57 | 16.06 | 29.21 | 20.65 | 9.50 |
| Cash & bank balances | 0.44 | 0.03 | 0.09 | 0.06 | 0.01 | 0.00 | 0.11 |
| Loans & advances | 5.90 | 5.76 | 2.90 | 11.26 | 3.33 | 5.84 | 4.23 |
| Total current assets | 118 | 119 | 85.83 | 98.58 | 82.32 | 64.19 | 52.83 |
| Total current liabilities | 17.38 | 22.06 | 14.85 | 7.62 | 9.68 | 12.83 | 7.00 |
| Net working capital | 101 | 96.45 | 70.98 | 90.96 | 72.64 | 51.36 | 45.83 |
| Total assets | 114 | 109 | 81.39 | 95.59 | 76.47 | 54.52 | 49.56 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.03 | 0.09 | 0.06 | 0.01 | 0.00 | 0.11 | 0.00 |
| Net cash from operating activities | 5.43 | (16.13) | 32.42 | (5.87) | (10.12) | 5.54 | (4.47) |
| Net cash from investing activities | (1.60) | (1.48) | (5.88) | 0.01 | (1.53) | (0.21) | 0.18 |
| Net cash from financing activities | (3.43) | 17.55 | (26.51) | 5.92 | 11.66 | (5.44) | 4.40 |
| Net change in cash | 0.40 | (0.06) | 0.03 | 0.06 | 0.01 | (0.11) | 0.11 |
| Closing cash | 0.44 | 0.03 | 0.09 | 0.06 | 0.01 | 0.00 | 0.11 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +43.0% | +9.0% | -22.0% | +23.1% | -17.8% | +60.3% | - |
| EBITDA growth | -8.6% | -24.9% | -3.0% | +9.1% | -1.8% | +232.6% | - |
| PBT growth | -18.1% | -25.8% | +3.2% | +6.5% | -1.8% | +489.3% | +6.1% |
| Net income growth | -15.6% | -27.6% | +2.4% | +7.4% | -1.9% | +485.3% | - |
| Revenue CAGR (3Y) | +6.7% | +1.5% | -7.6% | +17.5% | +18.1% | +22.2% | +5.8% |
| EBITDA CAGR (3Y) | -12.7% | -7.4% | +1.3% | +52.8% | +46.7% | +42.2% | -0.9% |
| Profitability & leverage | |||||||
| Net income margin | +1.8% | +3.1% | +4.6% | +3.5% | +4.0% | +3.3% | +0.9% |
| Return on capital employed | - | +13.3% | +18.7% | +19.6% | +22.8% | +29.1% | +8.6% |
| Return on net worth | - | +12.9% | +20.2% | +24.4% | +29.5% | +43.0% | +10.1% |
| Debt / equity | - | 0.45 | 0.59 | 0.92 | 0.90 | 1.15 | 1.57 |
| Long-term debt / equity | - | 0.02 | 0.04 | 0.07 | 0.10 | 0.17 | 0.15 |
| Interest cover | 16.85 | 9.55 | 6.83 | 11.64 | 6.01 | 5.43 | 41.76 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 20.55 | 19.73 | 26.37 | 23.95 | 47.86 | 29.15 |
| Inventory turnover | - | 2.81 | 3.26 | 5.21 | 5.85 | 8.11 | 5.68 |
| Debtors turnover | - | 107.73 | 25.02 | 13.91 | 10.26 | 20.64 | 19.08 |
| EPS (₹) | 0.18 | 0.22 | 0.30 | 8.74 | 24.42 | 24.91 | 4.36 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 1.85 | 1.63 | 39.85 | 94.95 | 70.34 | 45.43 |
To see the full year-wise statements and ratios of M K Proteins Limited, buy the company report.
Board of directors of M K Proteins Limited
M K Proteins has 8 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Parvind Kumar Also directs: SGF Industries Private Limited, Kamla Oleo Private Limited, Shree Ganesh Fats Pvt Ltd and 3 more | Director | 15 Jun 2012 | 14 Years 4 Months | Current |
| Raj Kumar Also directs: SGF Industries Private Limited, Kamla Oleo Private Limited, Shree Ganesh Fats Pvt Ltd and 1 more | Director | 15 Jun 2012 | 14 Years 4 Months | Current |
| Parmod Kumar Also directs: Kamla Oleo Private Limited, Shree Ganesh Fats Pvt Ltd, Shib Charan Dass Industries Private Limited and 2 more | Managing Director | 15 Feb 2017 | 9 Years 8 Months | Current |
| Vinod Kumar Also directs: SGF Industries Private Limited, Kamla Oleo Private Limited, Shree Ganesh Fats Pvt Ltd and 2 more | Whole-Time Director | 10 Dec 2016 | 9 Years 11 Months | Current |
| Deepak Khetarpal | Director | 23 Aug 2025 | 1 Years 2 Months | Current |
| Tej Mohan Singh Also directs: Omara Ventures India Private Limited | Director | 05 May 2023 | 3 Years 6 Months | Current |
Auditor
M K Proteins Limited is audited by KRA & Co. for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KRA & Co. | FY 2025 | 020266N |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 74.80%, foreign institutional investors hold 0.00%, domestic institutional investors hold 0.00% and retail and other public shareholders hold 25.20%.
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 74.80% | 74.80% | 74.80% | 74.80% |
| Public | 25.20% | 25.20% | 25.20% | 25.20% |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Mar 2026 | 101294089 | Hdfc Bank Limited | ₹85 Lakh | Open | |
| 21 Oct 2024 | 101012952 | Hdfc Bank Limited | ₹1.33 Cr | Open | |
| 05 Apr 2021 | 100448101 | Hdfc Bank Limited | ₹34.47 Lakh | Open | |
| 04 Sep 2014 | 10526525 | Hdfc Bank Limited | ₹40 Cr | Open | |
| 14 Dec 2012 | 10394926 | Punjab National Bank | ₹16.25 Cr | Satisfied |
To see the full charge records of M K Proteins Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
M K Proteins Limited has 36 deals on record (35 market trades, 1 ipo); the latest was in March 2024.
Deals on record (5 of 36)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Market trade | ₹11.98 Cr | Buyer: Shree Ganesh Fats Pvt Ltd Seller: Parmod Kumar Huf, 3 individuals |
| Mar 2024 | Market trade | ₹93.3 Lakh | Buyer: JTL Industries Limited Seller: JTL Industries Limited |
| Jan 2024 | Market trade | ₹35.62 Cr | Buyer: Multiplier Share and Stock Advisors Private Limited , Setu Securities Private Limited , 2 individuals Seller: Multiplier Share and Stock Advisors Private Limited , Setu Securities Private Limited , Mansi Share And Stock Advisors Pvt Ltd, an individual |
| Jan 2024 | Market trade | ₹24.32 Cr | Buyer: Multiplier Share and Stock Advisors Private Limited , Mansi Share And Stock Advisors Pvt Ltd, Setu Securities Private Limited , an individual Seller: Multiplier Share and Stock Advisors Private Limited , Setu Securities Private Limited , Mansi Share And Stock Advisors Pvt Ltd |
| Jan 2024 | Market trade | ₹9.22 Cr | Buyer: Graviton Research Capital LLP , an individual Seller: Graviton Research Capital LLP , an individual |
To see the full deal history of M K Proteins Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
M K Proteins Limited has 12 court cases on record: 6 filed by M K Proteins, 6 filed against it. 3 cases are pending and 9 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 6 | 0 | 1 |
| Supreme Court | 6 | 6 | 2 |
Cases on record (5 of 12)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Supreme Court | Court case (1601-Direct Taxation : Income Tax Act, 1961, Wealth Tax Act, 1957, Gift Tax Act, 1958, Excess Profits Tax Act, 1940, Business Profit Tax Act, 1947 [other than matters covered by categories 1602-1605]) | Filed against the company by Income Tax Officer Ward and 2 others | Disposed |
| Supreme Court | Court case | Filed against the company by Income Tax Officer Ward 1 | Pending |
| High Court of Punjab and Haryana | Writ petition | Filed by the company against Principal Commissioner CGST Rohtak and Others | Pending |
| Supreme Court | Appeal | Filed against the company by Income Tax Officer | Disposed |
| Supreme Court | Appeal | Filed against the company by Income Tax Officer Ward 1 | Disposed |
To see the full case history of M K Proteins Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
M K Proteins Limited was last rated by Crisil on 25 Aug 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 25 Aug 2021 |
To see the full credit ratings and regulatory alerts of M K Proteins Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for M K Proteins Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
M K Proteins Limited has a workforce of 52 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 52 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of M K Proteins Limited, buy the company report.
GST
M K Proteins has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAHCM9854C1ZB | Haryana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of M K Proteins Limited, buy the company report.
Recent activity
M K Proteins Limited has 24 board changes on record since 2012: 16 appointments and 8 cessations. The latest: Aritika Garg was appointed as Director on 22 Aug 2026.
23 earlier events are in the company report.
News
Frequently asked questions
M K Proteins is an active public limited company based in Ambala, Haryana, India. The company works in edible oils and cooking fats, within the food and beverages industry. It was incorporated on 15 June 2012 (14+ years old) and is registered under CIN L15500HR2012PLC046239. Listed on BSE: 543919 and NSE: MKPL.
M K Proteins reported revenue of ₹382.88 Cr for FY 2025-26 (up 43% YoY) based on standalone financials.
M K Proteins has 8 current directors:
- Parmod Kumar - Managing Director
- Vinod Kumar - Whole-Time Director
- Parvind Kumar - Director
- Raj Kumar - Director
- Deepak Khetarpal - Director
- Tej Mohan Singh - Director
- Shipra Jain - Director
- Aritika Garg - Director
The latest financial statements of M K Proteins on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 19 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of M K Proteins is 06AAHCM9854C1ZB, registered in Haryana.
The CIN (Corporate Identification Number) of M K Proteins is L15500HR2012PLC046239. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. M K Proteins is a listed company as per MCA records. Its shares are listed on both BSE (code: 543919) and NSE (symbol: MKPL).
M K Proteins has 12 court cases on record: 6 filed by the company and 6 filed against it. 3 are pending. Most are in the high courts.
M K Proteins was incorporated on 15 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Haryana.
M K Proteins has 36 deals on record (35 market trades, 1 ipo); the latest was in March 2024.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
